statistiche ricercatore

Continente	#
EU - Europa	621
NA - Nord America	500
AS - Asia	290
SA - Sud America	90
Continente sconosciuto - Info sul continente non disponibili	11
AF - Africa	9
OC - Oceania	1
Totale	1.522

Nazione	#
US - Stati Uniti d'America	480
RU - Federazione Russa	356
SG - Singapore	113
CN - Cina	80
BR - Brasile	76
IE - Irlanda	69
SE - Svezia	61
HK - Hong Kong	30
GB - Regno Unito	29
VN - Vietnam	26
FR - Francia	25
DE - Germania	24
IT - Italia	15
FI - Finlandia	11
UA - Ucraina	10
IN - India	8
CA - Canada	7
BD - Bangladesh	6
JP - Giappone	5
PL - Polonia	5
AR - Argentina	4
MX - Messico	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
BE - Belgio	3
CR - Costa Rica	3
EC - Ecuador	3
IQ - Iraq	3
AL - Albania	2
AZ - Azerbaigian	2
CO - Colombia	2
EE - Estonia	2
ES - Italia	2
LT - Lituania	2
MA - Marocco	2
PK - Pakistan	2
PY - Paraguay	2
SA - Arabia Saudita	2
TN - Tunisia	2
TR - Turchia	2
TT - Trinidad e Tobago	2
AT - Austria	1
AU - Australia	1
BH - Bahrain	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GE - Georgia	1
GP - Guadalupe	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
LU - Lussemburgo	1
NI - Nicaragua	1
NL - Olanda	1
PT - Portogallo	1
RS - Serbia	1
UY - Uruguay	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.512

Nome	#
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach	230
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia	172
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series	148
Metacognition and negative emotions in clinical practice. A preliminary study with patients with bowel disorder	135
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy.	134
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions.	134
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy.	130
Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?	110
Crucial factors? Patient adherence	108
Clinical drug response to thiopurines is associated with a lower interferon-γ production by IBD patient’s T lymphocytes.	100
Radioactivity Content and Dosimetric Assessment in Bovine Meat from the Calabria Region, Southern Italy	84
null	20
null	17
Totale	1.522

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	59	0	0	0	0	2	1	0	2	2	25	4	23
2022/2023	190	12	23	6	22	12	19	0	9	79	1	6	1
2023/2024	52	3	5	4	13	3	10	0	3	0	3	1	7
2024/2025	214	0	4	3	14	8	11	3	40	68	13	19	31
2025/2026	779	35	40	54	43	70	168	103	105	106	35	9	11
2026/2027	97	9	24	25	30	9	0	0	0	0	0	0	0
Totale													1.522